✕
Model Search
Request a Quote
Why LIDE
Preclinical Focus, Clinical Mindset
Global Leadership, Local Support
Commitment to Operational Excellence
Verified on Scientist.com
Our Science
MiniPDX® 7 Day In Vivo Organoid
Assay Details and Readout
Application in Drug R&D
MiniPDX at the Clinic
MiniPDX for IO: IO-FIVE®
Patient‑Derived Xenograft (PDX) Models
Cell Line-Derived Xenograft (CDX) Models
Orthotopic Models
Syngeneic Models
Humanized Models
Autoimmune Disease Models
Ex Vivo Models
3D Spheroid and Organoid Assays
CR (Conditionally Reprogrammed) Cells
Co-Culture Assays for IO
Multi-omics Analysis
OncoVee™ K-Cell 1000 Cell Kit
Transcription Analysis & Bioinformatics
Sequencing and Functional Genomic Imaging (FGI)
Multiplex Tissue Imaging
Our Services
By Therapeutic Area or Modality
Preclinical Oncology Studies
Immuno-Oncology (IO) Platform
Hematological Malignancies – Blood Cancers
Drug Resistant Cancers
Accelerating ADC Development
By Model System
In-vivo Models and Studies
In-vitro Models and Studies
By Research Phase
Target Identification & HIT Discovery
Lead Optimization and Preclinical Validation
Clinical Testing
Getting Started
Contract Research for Drug R&D
Academic Collaborations
Buying Models
Contact Us
Home
/ Why LIDE
Why LIDE